Dengue virus infection in the central nervous system (CNS) of immunized mice results in a strong in¯ux of CD8 T cells into the brain. Whereas the kinetics of the splenic antiviral response are conventional, i.e. expansion followed by a rapid drop in the frequency of speci®c CD8 T cells, dengue virus-speci®c CD8 T cells are retained in the CNS at a high frequency. These CD8 T cells display a partially activated phenotype (CD69 high , Ly-6A/E high , CD62L low ), characteristic for effector-memory T cells. CD43 expression, visualized by staining with the 1B11 mAb, decreased in time, suggesting that these persisting CD8 T cells differentiated into memory cells. These data add to the growing evidence implicating the CNS as a non-lymphoid tissue capable of supporting prolonged T cell survival/maintenance.
Introduction
Most of our understanding of immunological memory comes from the analysis of memory cells in lymphoid tissues. However, it is becoming increasingly clear in mouse models that long-lived memory T cells are also present in nonlymphoid tissues (1±8). Several studies have indicated that non-lymphoid memory cells exhibit an activated phenotype (1±3), leading to the proposition that these cells represent an in situ rapid response force. Consistent with these ideas, two subsets of human memory T cells have recently been described, central and effector-memory cells, that differ in the expression of the chemokine receptor CCR7 and the lymphoid homing marker L-selectin (CD62L) (8) . Whereas central memory cells (CCR7 high /CD62L high ) represent classical lymphoid memory cells, effector-memory cells (CCR7 low / CD62L low ) circulate outside the lymphoid organs and were found to maintain various effector functions (8) . It should be noted though that phenotypic classi®cation of CD8 T cells during chronic human infection may be more complex: memory CD8 T cells appear to accumulate at different points along the differentiation pathway in different infections (9) . At least three different phenotypes can be distinguished based on CD27 and CD28 expression (9) . From these studies it was concluded that human memory CD8 T cells would be better de®ned on the basis of their activation status (9) . Thus, comparing phenotypes between human and murine infections can be problematic.
In the present study, we have found evidence for long-lived effector-memory T cells in the brains of dengue viruschallenged mice. Previously, evidence for persisting antiviral CD8 T cells in the central nervous system (CNS) has come from experiments in which immunized mice were intranasally challenged with a neurotropic strain of in¯uenza virus (1) . In the brains of these mice, in¯uenza-speci®c CD8 T cells persisted for up to 320 days in a partially activated state (CD62L low , CD25 low , CD69 high ) (1). Additionally, primary infection of mice with a neurotropic strain of the coronavirus mouse hepatitis virus (MHV) also leads to prolonged presence of antiviral T cells in the CNS (10±12).
In our study, we have analyzed persisting CD8 T cells in the brains of immunized mice surviving dengue challenge. Intracranial challenge of naive mice with dengue virus induces lethal encephalitis (13, 14) , accompanied by a weak antiviral CD8 T cell response (15) . Only low frequencies of dengue virus-speci®c CD8 T cells can be detected in the spleens and in the brains of encephalitic mice (15) . In contrast, immunized mice control the dengue virus challenge (13±15): immunization primes a cellular immune response that is effectively recruited in the CNS after intracranial challenge, similar to that described for in¯uenza virus encephalitis (1) . A detailed phenotypic analysis of these CNS-resident T cells indicates that they should be categorized as effector-memory T cells.
Methods

Cells and virus
The chimeric YF/DEN virus (15) was grown on SW-13 cells, which were propagated in minimal essential medium supplemented with 10% FCS, 2 mM L-glutamine, antibiotics and nonessential amino acids. The vaccinia virus recombinant expressing pre-membrane (prM) and envelope (E) from dengue-2 virus (16) was provided by Dr Ching-Juh Lai (National Institutes of Health, Bethesda, MD). A20 cells were propagated in RPMI supplemented with 10% FCS, 2 mM L-glutamine and antibiotics.
Immunization and challenge of mice
Three-week-old BALB/c mice (Jackson Laboratory, Bar Harbor, ME) were immunized by s.c. injection of 5 Q 10 5 p.f.u. of the chimeric YF/DEN virus. Results of control immunizations with PBS or with the parental yellow fever virus (YFV)-17D strain have been described previously (15) . Mice were challenged 2 weeks after immunization by intracranial injection of 1.5 Q 10 4 p.f.u. (100 50% lethal doses) of mouse-adapted, neurovirulent dengue-2 virus (strain New Guinea C; kindly provided by Dr Kenneth Eckels, Walter Reed Army Institute for Research, Rockville, MD) (13, 14) .
Isolation of lymphocytes from mouse brain
Isolation of lymphocytes from the brains of YF/DEN immunized and dengue-2 virus-challenged mice was done as described previously (10, 11, 12, 15) . Brie¯y, mouse brains were homogenized using a Tenbroeck homogenizer and lymphocytes were isolated by centrifugation over a Percoll cushion.
Lymphocyte staining and¯ow cytometry
Lymphocytes from the CNS and splenocytes were stained using FITC-labeled mAb against CD62L, CD69, CD25 and CD11a (LFA-1) (clones MEL-14, H1.2F3, 7D4 and 2D7 respectively), R-phycoerythrin (PE)-conjugated antibodies against CD43, Ly6A/E, CD122 and CD80 (B7.1) (clones 1B11, D7, TM-b1 and 16-10A1 respectively), and allophycocyanin (APC)-labeled anti-CD8 (clone 53-6.7). Intracellular staining to detect IFN-g-producing T cells was done as described (15) . Brie¯y, A20 stimulator cells were infected with the prM-E-expressing vaccinia virus recombinant (15) at a m.o.i. = 1. Infected cells (2 Q 10 5 ) were used at 8 h postinfection, at which time they were incubated with 8 Q 10 5 splenocytes or CNS lymphocytes, in the presence of Brefeldin A (PharMingen, San Diego, CA). As a control, cells were left unstimulated. After a 6-h incubation, cells were surface stained with FITC-labeled anti-CD4 (clone GK1.5) and PE-conjugated anti-CD8 (clone 53-6.7) antibodies. Following ®xation and permeabilization (Cyto®x/Cytperm kit; PharMingen), intracellular staining was performed using an APC-conjugated antibody against IFN-g (clone XMG1.2). Samples were acquired using a FACSCalibur¯ow cytometer and analyzed using CellQuest software (Becton Dickinson, San Jose, CA). All mAb were obtained from PharMingen.
Results
Antiviral CD8 T cells persist in the brains, but not in the spleens, of dengue virus-infected mice
In our vaccination/challenge model, BALB/c mice were ®rst immunized using a YFV/dengue chimeric virus (15) . As described before, this recombinant virus expresses the prM and E genes from dengue-2 virus in a YFV-17D genetic background (15) , and will therefore induce responses speci®c for the dengue virus prM-E proteins. Based on the rules of prime-boost immunization (17), it can be expected that the dengue-speci®c T cell response after challenge will be predominantly directed against the two dengue proteins which were used for priming, i.e. prM and E. Thus, we have measured dengue virus prM-and E-speci®c T cell responses in the spleen and in the CNS, both after immunization and after the challenge (15) . To present the dengue virus prM and E proteins we used a recombinant vaccinia virus expressing prM and E (16) to infect syngeneic A20 cells (15) . Responses were quantitated by intracellular IFN-g staining.
After immunization, dengue virus prM-E-speci®c CD8 T cell responses were readily detected in the spleen at a frequency of 0.5% of the total CD8 T cell population (day 14 postimmunization, Fig. 1 ). We did observe some migration of CD8 T cells into the CNS, with 5±6% of these cells responding to dengue virus prM and E antigens ( Fig. 1 ). However, it should be noted that the number of CD8 + IFN-g + events was very small and that the brains had not been perfused. Therefore, it cannot be rigorously excluded that we observed responses from peripheral blood. At 14 days post-immunization, mice were challenged intracranially with a mouse-adapted, neurovirulent strain of dengue-2 virus (13) . Whereas 13 out of 15 nonimmunized control mice succumbed to the ensuing dengue encephalitis, only one out of 12 immunized mice developed symptoms (15) . In the spleens of immunized and challenged mice, we found that up to 4% of CD8 T cells were prM-E speci®c at day 5 post-challenge ( Fig. 1) (15) . In addition, we measured a strong in¯ux of T cells into the CNS and 34% of CD8 T cells in the brain were prM-E speci®c at day 5 postchallenge ( Fig. 1 ). Thus, as expected, virus-speci®c T cells migrated to the site of infection, i.e. the CNS, during the acute response. Alternatively, it could be argued that a small population of CNS-resident prM-E-speci®c CD8 T cells, primed by the immunization, expanded after the challenge. Clearly, prM-E-speci®c effector T cells, both in the spleen and in the CNS, displayed CD8 down-regulation ( Fig. 1 and Table 1) .
Strikingly, however, we still detected high frequencies of prM-E-speci®c CD8 T cells in the CNS at 20, 40 and 56 days after the dengue virus challenge: 18±28% of CD8 T cells residing in the brain were speci®c for the dengue prM-E proteins at these timepoints ( Fig. 1 ). In addition, the absolute number of CD8 T cells in the brain did not decrease. Phenotypically, however, these cells did change: CD8 expression and the level of IFN-g production increased from day 5 to 56 (Table 1 ). In contrast, the kinetics of the splenic T cell response were more conventional: at day 56 post-challenge, only 0.4% of CD8 T cells were prM-E speci®c (Fig. 1 ). This 10fold decrease in the frequency of speci®c T cells in the transition from the effector phase to memory (the`death phase') corresponds well to observations in other (acute infection) models (17) . From these ®ndings, we concluded that virus-speci®c memory CD8 T cells preferentially persisted in the CNS.
Expression of CD43: kinetics of the cytolytic phenotype
As a ®rst phenotypic characterization, we analyzed the expression patterns of cell-surface O-glycans using the 1B11 mAb. This antibody recognizes the O-glycans on an activation-associated form of CD43 (19, 20) . Positive 1B11 staining identi®es the population of cytotoxic effector T cells that display direct ex vivo cytolytic activity (cytotoxic T lymphocytes) (19, 20) . Memory cells, in contrast, are 1B11 low (19, 20) . Figure 2 shows the CD43/1B11 expression levels on dengue virus prM-E-speci®c CD8 T cells in the brains and spleens, before and after immunization. As can be deduced from Fig. 2 , the prM-E speci®c T cells (i.e. IFN-g + cells) in the spleen and in the CNS were all 1B11 high at day 14 post-immunization, indicating that these cells are effector cytotoxic T lymphocytes. Although these cells may not yet have acquired a full memory phenotype (18, 19) , we consistently found solid protection and recruitment of prM-E-speci®c Values were determined using CellQuest software, based on the data shown in Fig. 1 .
CD8 T cells after challenge at 14 days post-infection (14) ( Fig. 1) . At days 20 and 56 post-challenge, we found that prM-E-speci®c CD8 T cells, in the spleen as well as in the CNS, expressed decreasing amounts of the 1B11 determinant (Fig. 2 ). This suggests that these cells were in the process of differentiating into memory cells (19, 20) . The kinetics of CD43 down-regulation were somewhat slower in the CNS as compared to the spleen. Alternatively, the loss of CD43 high CD8 T cells from the spleen at day 20 post-challenge could re¯ect migration of activated cells into the CNS. Nevertheless, our data suggest that the majority of prM-E-speci®c CD8 T cells retained in the CNS at day 56 post-challenge are non-cytolytic, based on their 1B11 expression patterns (19) .
Phenotypic characterization of CNS-resident CD8 T cells
We then characterized the entire population of CNS-resident T cells, by measuring the expression of several different activation makers. Analysis of this population (which includes the IFN-g + prM-E-speci®c CD8 T cells,~20±25%, but also other cells), shown in Fig. 3 , revealed that all CD8 T cells in the CNS expressed the 1B11 determinant at day 5 post-infection ( Fig. 3A) and were therefore most likely true cytotoxic T cells. Clearly, two 1B11 high CD8 T cell populations can be distinguished, and, as shown in Fig. 4 , these populations appear to differ in the expression level of CD69, and, therefore, possibly in their activation status. Re¯ecting the differentiation pattern of the IFN-g + prM-E-speci®c CD8 T cells, CD43 expression levels were decreasing in the entire population of CNSresident CD8 T cells at day 56 post-infection, although 1B11 high CD8 T cells were still present. Thus, CNS-resident CD8 T cells were heterogeneous in their 1B11 expression patterns. On the other hand, the expression patterns of several activation and homing markers (CD69, Ly6A/E and CD62L) suggested an activated phenotype. A large majority of CD8 T cells in the CNS had down-regulated L-selectin (CD62L low ), both at day 5 (85%) and day 56 (89%) post-infection (Fig. 3B) , consistent with their non-lymphoid localization. In addition, the vast majority of the CD8 T cells in the brain were CD69 high (89%) and Ly-6A/E high (80%) at day 56 post-infection ( Fig. 3C  and D) . CD69 and Ly-6A/E were also up-regulated in day 5 effector cells ( Fig. 3C and D) , although expression levels at day 5 were more heterogeneous than at day 56. The differences between the CD8 T cell populations at days 5 and 56 are most clearly illustrated by double-staining for CD69 and 1B11/CD43: at day 56, more cells have up-regulated CD69 expression and down-regulated CD43/1B11 expression ( Fig. 4) . As a control, expression levels of CD43, CD62L, CD69 and Ly-6A/E in day 5 and 56 spleen cells are shown in Fig. 3 : these CD8 T cells are 1B11 low , CD62L high , CD69 low and Ly-6A/ E low . No changes in the expression levels of CD25 (IL-2Ra), CD122 (IL-2Rg), B7.1 and CD11a (LFA-1) were observed when comparing splenic and CNS-derived lymphocytes at days 5 and 56 post-challenge (data not shown). Expression levels of CD25, CD122 and B7.1 were uniformly low, and LFA-1 expression was high on all CD8 T lymphocytes.
Discussion
In the present study, we have found that virus-speci®c CD8 T cells persisted at the site of infection and that these cells displayed a unique phenotype, featuring traits from both memory (CD43/1B11 low ) and activated T cells (CD62L low , CD69 high , Ly6A/E high ). The CD43 expression pattern of the population of CNS-resident CD8 T cells changes from (biphasic) CD43 high at day 5 post-challenge towards a more heterogeneous pattern at day 56 post-challenge Thus, it appears that the majority of CD8 T cells are differentiating into memory cells, as judged by CD43 expression (19, 20) . Based on the strong correlation between CD43 (1B11) expression and direct ex vivo cytotoxicity (19) , this would suggest that fewer CD8 cells would display direct ex vivo cytotoxicity at day 56. Clearly, dengue virus-speci®c CD8 T cells expressed low levels of the 1B11/CD43 determinant at late timepoints. It should be noted, however, that cytolytic clearance may not play a major role in the CNS, especially in the case of infected neurons. Instead, it has been shown in several viral infection models that T cells use IFN-g to clear virus from the brain (21± 23). In this respect, an activated phenotype may be more important than direct ex vivo cytotoxicity in the brain.
The expression patterns of CD69 and Ly6A/E were striking: expression levels of these activation markers were higher and more homogenous at day 56 post-challenge than immediately after challenge. This same pattern (i.e. heterogeneous CD69 expression during acute encephalitis and uniform high expression late after infection) was seen in mice infected with a neurovirulent strains of in¯uenza virus (1) or MHV (10) . As pointed out by Bergmann et al., CD69 expression is a common hallmark of CD8 T cells retained in the CNS (10, 11) . The CNS-resident CD8 T cells after dengue virus infection were CD69 high and also CD25 low , similar to antiviral CD8 T cells in the brains of MHV-infected rats and mice (10, 24) . It has been suggested that the phenotype of these cells re¯ects a state of`anergy post-activation' (10, 25) . Alternatively, as discussed below, CD69 may play a role in the regulation of T cell traf®cking (26) and persistent CD69 up-regulation could be involved in T cell retention.
Our study raises three important questions. The ®rst question relates to the speci®city of the majority of CNS-resident CD8 T cells that are not prM-E speci®c. In our view, there are three explanations. (i) We may be observing cells with unknown speci®cities that migrated into the brain through bystander activation. (ii) The remaining CD8 T cells could recognize other dengue virus epitopes, outside the prM-E proteins. It is possible that other epitopes, cross-reactive in the YFV vaccine and the dengue challenge virus (e.g. from the conserved NS5 polymerase protein), are responsible for the expansion of T cells. (iii) There may be a population of prM-E-speci®c CD8 T cells that failed to produce IFN-g upon antigenic stimulation. Inactivated CD8 T cells have been detected previously in the context of antiviral responses (27±29). The second question is perhaps the most important issue raised by our experiments and by several earlier studies (1, 10, 11) : why are virus-speci®c CD8 T cells retained in the brain and what keeps them in a partially activated state? There has been some debate on the role of persisting antigen in retaining T cells in the brain. Hawke et al. observed persisting antiviral CD8 T cells in the absence of antigen after challenge of immunized mice with in¯uenza virus (1). However, as proposed by these authors (1) and given the extreme sensitivity of CD8 T cells (30) , it is possible that CD8 T cells are retained by persisting MHC class I±peptide complexes on neuronal cells that are below the threshold of detection. Marten et al., in contrast, reported that retention of both CD4 and CD8 T cells in the brains of MHV-infected mice strictly coincided with the presence of viral RNA (11). These authors have provided two explanations for the observed differences (11) . (i) T cells recruited during secondary in¯uenza virus infection are memory cells, whereas primary cells are induced during MHV infection. (ii) In¯uenza virus infects neurons, which express low levels of MHC class I molecules (31, 32) , whereas MHV predominantly infects microglia and astrocytes, which express higher levels of both MHC class I and class II molecules (11) . Clearly, our dengue virus infection model is more similar to secondary in¯uenza virus infection: the intracranial dengue virus infection recruits memory T cells (induced by s.c. vaccination) and dengue virus has a neuronal tropism in mice (33) . These differences should also be interpreted in the light of the complex phenotypic differences seen in human chronic infections (9) : MHV does establish a persistent infection in mice (10, 11) , whereas in¯uenza virus evidently does not (1) . It is unclear whether dengue virus persists after the acute encephalitis and this will be a subject for further investigation. Importantly, however, the CD4 T cell Fig. 4 . Lymphocytes harvested from the CNS at days 5 and 56 were stained with APC-conjugated anti-CD8 mAb and FITC-conjugated anti-CD69 and PE-conjugated anti-CD43. Cells were gated on CD8 expression. response in the brain (the CD8 ± IFN-g + cells in Fig. 1 ) (14) strongly decreased from day 5 to 56. This decreasing CD4 T cell response is inconsistent with persistence of antigen, as shown by Marten et al. (11) in the case of persisting T cell responses against MHV. Thus, in the absence of antigen, CD4 T cells ef¯ux from the CNS (11, 34) , whereas CD8 T cells can persist (1) . A third issue that needs further investigation is the homing potential of the CNS-resident CD8 T cells [reviewed in (35) ]. It is currently unclear whether these cells express homing markers speci®c for the brain or a set of markers that merely speci®es non-lymphoid localization, irrespective of the tissue. One intriguing possibility is that CD69 plays a role in the retention of T cells in tissues. Recent results using CD69 transgenic mice indicate that thymocytes that constitutively express CD69 are retained in the thymus (26) . This may implicate CD69 in the regulation of T cell traf®cking, as suggested by the authors (26) . In addition, CD43 (i.e. the high mol. wt form detected by the 1B11 antibody) may play a role in CNS localization: antigen-speci®c CD8 T cells do not migrate into the brains of CD43 knockout mice that are intracerebrally infected with lymphocytic choriomeningitis virus (20) .
In conclusion, we hypothesize that the prM-E-speci®c CD8 T cells form a pool of local, activated memory cells that is independent and phenotypically different from the peripheral (lymphoid) memory T cell pool.
